Suppr超能文献

原发性不明的盆腔鳞状细胞癌伴肾积水和输尿管狭窄:一例报告

Pelvic squamous cell carcinoma of unknown primary origin with hydronephrosis and ureteral stricture: A case report.

作者信息

Meng Wenjun, Gao Yuchen, Pan Lu, Zhao Guowei, Chen Qi, Bai Lian, Zheng Rujun

机构信息

Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.

Department of General Surgery, Beijing Mentougou District Hospital, Beijing, China.

出版信息

Medicine (Baltimore). 2024 Jan 26;103(4):e37057. doi: 10.1097/MD.0000000000037057.

Abstract

BACKGROUND

Cancer of unknown primary (CUP) is a very challenging disease, accounting for 2% to 9% of all new cancer cases. This type of tumor is a heterogeneous tumor whose primary site cannot be determined by standard examination. It has the characteristics of early metastasis, strong aggressiveness, and unpredictable mode of metastasis. Studies have shown that there is no consensus on the treatment of CUP and that there is a wide range of individual differences. In most cases, surgical removal of tumor is the most typical treatment for pelvic tumors. Herein, we report a case of a large pelvic tumor of unknown origin that had compressed the sigmoid colon and ureter and was completely removed by surgery. Postoperative diagnosis was pelvic metastatic squamous cell carcinoma.

CASE SUMMARY

A 68-year-old man with pelvic tumor who initially complained of recurrent low back pain and painful urination. The mass was initially diagnosed as a pelvic tumor of unknown origin. The patient underwent complete resection of the tumor by laparotomy. The tumor was pathologically diagnosed as squamous cell carcinoma.

CONCLUSION

Based on the treatment experience of this case, surgery alone cannot improve the poor prognosis of CUP. Since chemotherapy and immunotherapy have achieved promising efficacy in various cancers, and immunotherapy has the characteristics of low side effects and good tolerability, we recommend that patients with CUP should receive chemotherapy and/or immunotherapy for better survival outcomes.

摘要

背景

原发灶不明的癌症(CUP)是一种极具挑战性的疾病,占所有新发癌症病例的2%至9%。这类肿瘤是一种异质性肿瘤,其原发部位无法通过标准检查确定。它具有早期转移、侵袭性强和转移方式不可预测的特点。研究表明,对于CUP的治疗尚无共识,且个体差异很大。在大多数情况下,手术切除肿瘤是盆腔肿瘤最典型的治疗方法。在此,我们报告一例起源不明的巨大盆腔肿瘤病例,该肿瘤压迫乙状结肠和输尿管,经手术完全切除。术后诊断为盆腔转移性鳞状细胞癌。

病例摘要

一名68岁男性患有盆腔肿瘤,最初主诉反复腰痛和尿痛。该肿块最初被诊断为起源不明的盆腔肿瘤。患者通过剖腹手术进行了肿瘤的完全切除。肿瘤经病理诊断为鳞状细胞癌。

结论

基于该病例的治疗经验,单纯手术无法改善CUP的不良预后。由于化疗和免疫疗法在各种癌症中已取得了有前景的疗效,且免疫疗法具有副作用低、耐受性好的特点,我们建议CUP患者应接受化疗和/或免疫疗法以获得更好的生存结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e0f/10817135/602d1cbd442c/medi-103-e37057-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验